Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Xevudy TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: sotrovimab
Pack: Xevudy 500 mg/8 mL injection, 8 mL vial
Brand name
(ARTG)
: XEVUDY sotrovimab 500 mg/8 mL concentrated injection solution for infusion, vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
XEVUDY has provisional approval for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (COVID-19) who do not require initiation of oxygen due to COVID-19 and who are at increased risk of progression to hospitalisation or death (see Section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical Trials).,The decision has been made on the basis of short term efficacy and safety data. Continued approval of this indication depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- a clear, colourless or yellow to brown concentrated injection solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient sotrovimab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.
Top results
RACGP - What is the COVID-19 treatment sotrovimab?
Reproduced with permission from The Royal Australian College of General Practitioners
Read more on RACGP - The Royal Australian College of General Practitioners website
![RACGP - The Royal Australian College of General Practitioners](https://media.healthdirect.org.au/images/logos/h40/racgp_master_rgb-f5ccb3.png)
What you need to know about COVID-19 - Immunisation Coalition
What you need to know about COVID-19 so you can protect yourself, your friends, family and the rest of the community.
Read more on Immunisation Coalition website
![Immunisation Coalition](https://media.healthdirect.org.au/images/logos/h40/immunisation-coalition-logo-84853b.png)
Top results
RACGP - What is the COVID-19 treatment sotrovimab?
Reproduced with permission from The Royal Australian College of General Practitioners
Read more on RACGP - The Royal Australian College of General Practitioners website
![RACGP - The Royal Australian College of General Practitioners](https://media.healthdirect.org.au/images/logos/h40/racgp_master_rgb-f5ccb3.png)